US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 66.205
  • +0.475+0.72%
Trading Jan 2 10:08 ET
12.62BMarket Cap39.88P/E (TTM)

About Biomarin Pharmaceutical Company

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Company Profile

SymbolBMRN
Company NameBiomarin Pharmaceutical
Listing DateJul 23, 1999
Issue Price13.00
Founded1997
CEOMr. Alexander Hardy
MarketNASDAQ
Employees3401
Fiscal Year Ends12-31
Address770 Lindaro Street
CitySan Rafael
ProvinceCalifornia
CountryUnited States of America
Zip Code94901
Phone1-415-506-6700
Websitehttp://www.biomarin.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander Hardy
  • Director, President and Chief Executive Officer
  • 17.88M
  • Charles Greg Guyer
  • Chief Technical Officer and Executive Vice President
  • 5.70M
  • Dr. Greg Friberg
  • President, Chief Worldwide Research and Development Officer
  • --
  • Brian R. Mueller
  • Executive Vice President and Chief Financial Officer
  • 4.85M
  • Erin Burkhart
  • Group Vice President and Chief Accounting Officer
  • --
  • G. Eric Davis
  • Executive Vice President, Chief Legal Officer and Secretary
  • --
  • Richard A. Meier
  • Chairman of the Board
  • 515.44K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 470.44K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 480.44K
  • Robert J. Hombach
  • Independent Director
  • 486.94K
  • Mark Joseph Enyedy
  • Independent Director
  • 213.38K
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 480.44K
  • Dr. Elaine J. Heron,PhD
  • Independent Director
  • 486.44K
  • Dr. Athena Countouriotis, M.D.
  • Independent Director
  • 213.38K
  • Barbara W. Bodem
  • Independent Director
  • 213.38K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 473.94K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+4.86%
New Fortress Energy
NFE
+4.76%
SilverCrest Metals
SILV
+4.13%
Dorian LPG
LPG
+4.43%
Precision Drilling
PDS
+1.98%

Unlock the Full List